老虎证券

BUZZ-Capricor Therapeutics rises on meeting with US FDA for muscle disorder therapy

Reuters
2025/08/08
BUZZ-Capricor <a href="https://laohu8.com/S/LENZ">Therapeutics</a> rises on meeting with US FDA for muscle disorder therapy

** Shares of therapy developer Capricor Therapeutics CAPR.O up 3.22% at $8.33 premarket

** Co says meeting with U.S. FDA has been scheduled to discuss regulatory path of its cell therapy for treatment of cardiomyopathy associated with Duchenne muscular dystrophy, which is type of muscle disorder

** To accommodate this meeting, co has rescheduled release of its Q2 results to August 11 from August 12

** FDA in July declined to approved Deramiocel, saying the therapy does not meet efficacy requirements and asked for more data

** Up to last close, stock down 41.5% YTD

(Reporting by Sriparna Roy in Bengaluru)

((Sriparna.Roy@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10